This brand name is authorized in Spain
The drug NEATENOL DIU contains a combination of these active pharmaceutical ingredients (APIs):
|
1
Atenolol
UNII 6DI0UT7U1Q - ATENOLOL HYDROCHLORIDE
|
|
Atenolol is a beta-blocker which is beta1-selective, (i.e. acts preferentially on beta1-adrenergic receptors in the heart). Atenolol is without intrinsic sympathomimetic and membrane-stabilising activities and as with other beta-blockers, has negative inotropic effects. |
|
2
Bendroflumethiazide
UNII 5Q52X6ICJI - BENDROFLUMETHIAZIDE
|
|
Bendroflumethiazide inhibits the renal tubular absorption of salt and water by its action at the beginning of the distal convoluted tubule. Sodium and chloride ions are excreted in equivalent proportions. |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| C07BB03 | Atenolol and thiazides | C Cardiovascular system → C07 Beta blocking agents → C07B Beta blocking agents and thiazides → C07BB Beta blocking agents, non-selective, and thiazides |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: ES | Centro de información online de medicamentos de la AEMPS | Identifier(s): 56535 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
